GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Wanbangde Pharmaceutical Holding Group Co Ltd (SZSE:002082) » Definitions » Total Assets

Wanbangde Pharmaceutical Holding Group Co (SZSE:002082) Total Assets : ¥4,407 Mil (As of Mar. 2024)


View and export this data going back to 2006. Start your Free Trial

What is Wanbangde Pharmaceutical Holding Group Co Total Assets?

Wanbangde Pharmaceutical Holding Group Co's Total Assets for the quarter that ended in Mar. 2024 was ¥4,407 Mil.

During the past 12 months, Wanbangde Pharmaceutical Holding Group Co's average Total Assets Growth Rate was 5.70% per year. During the past 3 years, the average Total Assets Growth Rate was -7.20% per year. During the past 5 years, the average Total Assets Growth Rate was 5.70% per year. During the past 10 years, the average Total Assets Growth Rate was 16.60% per year.

During the past 13 years, Wanbangde Pharmaceutical Holding Group Co's highest 3-Year average Total Assets Growth Rate was 57.80%. The lowest was -7.20%. And the median was 13.80%.

Total Assets is connected with ROA %. Wanbangde Pharmaceutical Holding Group Co's annualized ROA % for the quarter that ended in Mar. 2024 was 2.65%. Total Assets is also linked to Revenue through Asset Turnover. Wanbangde Pharmaceutical Holding Group Co's Asset Turnover for the quarter that ended in Mar. 2024 was 0.10.


Wanbangde Pharmaceutical Holding Group Co Total Assets Historical Data

The historical data trend for Wanbangde Pharmaceutical Holding Group Co's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wanbangde Pharmaceutical Holding Group Co Total Assets Chart

Wanbangde Pharmaceutical Holding Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5,109.47 5,664.58 4,371.38 4,218.16 4,296.36

Wanbangde Pharmaceutical Holding Group Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4,434.59 4,375.47 4,380.33 4,296.36 4,406.60

Wanbangde Pharmaceutical Holding Group Co Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Wanbangde Pharmaceutical Holding Group Co's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (A: Dec. 2023 )+Total Liabilities (A: Dec. 2023 )
=2758.973+1537.385
=4,296

Wanbangde Pharmaceutical Holding Group Co's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets=Total Equity (Q: Mar. 2024 )+Total Liabilities (Q: Mar. 2024 )
=2787.987+1618.612
=4,407

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Wanbangde Pharmaceutical Holding Group Co  (SZSE:002082) Total Assets Explanation

Total Assets is connected with ROA %.

Wanbangde Pharmaceutical Holding Group Co's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %=Net Income (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=115.352/( (4296.358+4406.6)/ 2 )
=115.352/4351.479
=2.65 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Wanbangde Pharmaceutical Holding Group Co's Asset Turnover for the quarter that ended in Mar. 2024 is

Asset Turnover
=Revenue (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=429.173/( (4296.358+4406.6)/ 2 )
=429.173/4351.479
=0.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Wanbangde Pharmaceutical Holding Group Co Total Assets Related Terms

Thank you for viewing the detailed overview of Wanbangde Pharmaceutical Holding Group Co's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Wanbangde Pharmaceutical Holding Group Co (SZSE:002082) Business Description

Traded in Other Exchanges
N/A
Address
Dongliang Road 1688, Zhili Town, Zhejiang, Huzhou, CHN, 313008
Wanbangde Pharmaceutical Holding Group Co Ltd is mainly engaged in the pharmaceutical manufacturing and medical equipment-based health industry.
Executives
Zhao Shou Ming Directors, executives
Wang Tian Fang Director
Li Rong Fang Supervisors
Zhu Jian Xin Directors, executives
Yang Jin Rong Executives
Song Tie He Directors, executives
Song Jian Hua Executives
Pan Yun Chu Director
Yu Ju Ming Executives
Yang Mei Gen Executives
Tao Jian Feng Supervisors
Qian Shu Sheng Executives
Shen Bai Ming Director
Xu Yin Sheng Director
Shuang Zhi Wei Executives

Wanbangde Pharmaceutical Holding Group Co (SZSE:002082) Headlines

No Headlines